Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Luminescence ; 16(5): 315-9, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11590703

RESUMO

Water-soluble extracts of cigarette smoke are easily formed in some body compartments, such as saliva or fluid lining alveolar spaces, and can act on both cellular and extracellular compartments. In this paper we have analysed the effect of aqueous smoke extract on some metabolic and functional aspects of polymorphonuclear leukocytes. In particular, the following cellular aspects were studied: chemiluminescence, glycolysis, membrane fluidity and microscopic interaction with zymosan particles. While chemiluminescence and glycolytic activity are highly inhibited, no effect of smoke extract on membrane fluidity was observed. Moreover, the response of luminol-dependent chemiluminescence was significantly delayed, while that of lucigenin-dependent chemiluminescence was anticipated. Furthermore, the phagocytic ability of neutrophils pretreated with aqueous smoke extract was also significantly hindered. All these results might indicate that the finely tuned activity of polymorphonuclear leukocytes is somehow hampered by the aqueous extract of cigarette smoke in a way which makes these cells less effective against bacteria and more noxious towards surrounding tissues.


Assuntos
2-Naftilamina/análogos & derivados , Neutrófilos/fisiologia , Nicotiana/química , Fumaça/efeitos adversos , 2-Naftilamina/farmacologia , Acridinas/farmacologia , Glicemia/metabolismo , Corantes Fluorescentes/farmacologia , Fluorometria , Humanos , Cinética , Ácido Láctico/biossíntese , Lauratos/farmacologia , Medições Luminescentes , Luminol/farmacologia , Neutrófilos/efeitos dos fármacos , Neutrófilos/imunologia , Neutrófilos/metabolismo , Fagocitose/imunologia , Fumar/efeitos adversos , Fumar/sangue , Nicotiana/efeitos adversos
2.
Cell Death Differ ; 6(8): 781-7, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10467352

RESUMO

Bezafibrate belongs to the class of fibric acid derivatives usually used as antihyperlipidemia agents. From the biochemical point of view, these drugs show intriguing properties which leads one to think they may promote a differentiation process in tumour cells. This new pharmacological activity of fibrates could partially depend on the induction of an oxidative stress. To test this hypothesis, the effect of bezafibrate, as well as of clofibric acid and gemfibrozil, on growth, functional and cytochemical characteristics of human leukaemia-derived cell lines HL-60, U-937 and K-562 has been studied in some details. The results show that bezafibrate, gemfibrozil and clofibric acid, do induce differentiation in human myeloid leukaemia cell lines as indicated by several differentiation markers. Moreover fibrates, in dose dependent manner, significantly alter the cell cycle distributions, mainly leading to G0/G1 phase increment and G2/M phase reduction. The differentiating activity of fibrates could have significant implications both for the pharmacotoxicological profile of this class of compounds and for the pathophysiology of neoplastic disease.


Assuntos
Antineoplásicos/farmacologia , Bezafibrato/farmacologia , Inibidores do Crescimento/farmacologia , Acetilcisteína/farmacologia , Antioxidantes/farmacologia , Biomarcadores , Ciclo Celular/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Ácido Clofíbrico/análogos & derivados , Genfibrozila/farmacologia , Células HL-60 , Humanos , Integrina alfaXbeta2/biossíntese , Células K562 , Leucemia Mieloide , Receptores de Lipopolissacarídeos/biossíntese , Células U937
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...